XML 44 R27.htm IDEA: XBRL DOCUMENT
v3.22.4

REVENUE (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
REVENUE |
Schedule of Company's Disaggregation of Revenues | The following table summarizes the Company’s disaggregation of revenues: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | Year Ended December 31,
(U.S. dollars in thousands) | 2020 | ​ | 2021 |  | 2022
Pfizer | $ | 8,105 | ​ | $ | 10,160 | ​ | $ | 12,403
Brazil | $ | 8,000 | ​ | $ | 6,400 | ​ | $ | 9,452
Chiesi | ​ | 131 | ​ | $ | 189 | ​ | $ | 3,437
Total revenues from selling goods | $ | 16,236 | ​ | $ | 16,749 | ​ | $ | 25,292
Revenues from license and R&D services | $ | 46,662 | ​ | $ | 21,601 | ​ | $ | 22,346
​

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration